MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novartis AG Common Stock (NY:NVS)

145.46 +1.89 (+1.32%)
Official Closing Price Updated: 7:00 PM EDT, Sep 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,165,776
Open 144.57
Bid (Size) 142.70 (200)
Ask (Size) 146.00 (200)
Prev. Close 143.57
Today's Range 144.00 - 145.51
52wk Range 121.57 - 170.46
Shares Outstanding N/A
Dividend Yield 3.28%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Novartis (NYSE:NVS) Offers Dividend Investors a Quality Income Profile ↗
Via Chartmill
News headline image
Leaders Face Stark Warning from Silicon Valley Veteran – The Old Way of Working is Dead
Via Get News
Topics Artificial Intelligence

Performance

YTD
+5.0%
+5.0%
1 Month
-7.7%
-7.7%
3 Month
-6.4%
-6.4%
6 Month
-1.8%
-1.8%
1 Year
+19.0%
+19.0%

More News

Read More
News headline image
Where Will CRISPR Therapeutics Be in 10 Years if Gene Editing Fulfills Its Promise? ↗
Via The Motley Fool
News headline image
Worried About a Market Crash? This Dividend Stock Outperformed as the S&P 500 Sank in Both 2008 and 2022 ↗
Via The Motley Fool
Topics Economy Intellectual Property Stocks
News headline image
Novartis Suffers Another Setback After Two High-Profile Surprises Hammered Shares ↗
Via Investor's Business Daily
News headline image
VanEck Pharmaceutical ETF vs VanEck Biotech ETF: Which Fund Is Better for Drug Innovation Profits? ↗
Via The Motley Fool
Topics ETFs
News headline image
Novartis Just Shook Up a Multibillion-Dollar Drug Race. What It Means for Eli Lilly Stock. ↗
Via The Motley Fool
News headline image
Amgen Drops 10% on a Trial It Didn't Even Run ↗
Via MarketBeat
News headline image
Top Investor Urges Novartis for Stronger Acquisition Oversight After M&A and Trial Setbacks ↗
Via Benzinga
MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Lucid-MS Toward Phase 2 Trial Following FDA Clearance
Via Investor Brand Network
Historic First in MS Treatment Could Reshape a Multibillion-Dollar Therapeutics Market
Via Investor Brand Network
MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Advances Lucid-MS Toward Phase 2 Trial Following FDA Clearance
Via Investor Brand Network
News headline image
Historic First in MS Treatment Could Reshape a Multibillion-Dollar Therapeutics Market
From BioMedWire
Via GlobeNewswire
News headline image
2025 R&D Spending And Intensity Benchmarks
Via PRLog
Topics Supply Chain
News headline image
Stock Market Today, Sept. 8: Stocks Slide Amid Surging Oil Prices, Persistent Geopolotical Tenisons ↗
Via The Motley Fool
Topics Artificial Intelligence Stocks World Trade
News headline image
A Rivals Clinical Stumble Sends Sarepta Therapeutics Stock Lower ↗
Via Benzinga
News headline image
Novartis Myotonic Dystrophy Trial Flop Sends Dyne Therapeutics Shares Tumbling ↗
Via Benzinga
News headline image
How Novartis And Ionis' High-Profile Failure Reverberated Through Biopharma ↗
Via Investor's Business Daily
News headline image
Novartis, Ionis Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session ↗
Via Benzinga
News headline image
Novartis Stock Drops as Trial Failures Ripple Across Biotech Partners ↗
Via Benzinga
News headline image
United Natural Foods, ABM Industries and 3 Stocks to Watch Heading Into Tuesday ↗
Via Benzinga
News headline image
Novartis, Ionis Tumble On Surprise Flop For Heart Drug ↗
Via Investor's Business Daily
News headline image
A Wall Street Analyst Spotted the Trial Freeze—Then Came News of Three Deaths ↗
Via Benzinga
Topics Death
News headline image
The Multiple Sclerosis Drug Race Just Got Hotter After Novartis’ Phase 3 Win ↗
Via Benzinga
Tuesday's session: gap up and gap down stocks ↗
Via Chartmill

Frequently Asked Questions

Is Novartis AG Common Stock publicly traded?
Yes, Novartis AG Common Stock is publicly traded.
What exchange does Novartis AG Common Stock trade on?
Novartis AG Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novartis AG Common Stock?
The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
What is the current price of Novartis AG Common Stock?
The current price of Novartis AG Common Stock is 145.46
When was Novartis AG Common Stock last traded?
The last trade of Novartis AG Common Stock was at 09/25/26 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story